Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02999009 · ClinicalTrials.gov registry record · NA
Trident II Tritanium Acetabular Shell Outcomes Study
A NA study of Arthroplasty, Replacement, Hip, sponsored by Stryker Orthopaedics.
- Active
- Registry status
- NA
- Development phase
- 383
- Enrollment target
- 9
- Study locations
NCT02999009 is a NA study of Arthroplasty, Replacement, Hip that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 383 participants. The trial reports 9 study locations across 8 states.
The verdict
NCT02999009, a NA study of Arthroplasty, Replacement, Hip, is active but no longer recruiting, sponsored by Stryker Orthopaedics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 383 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Conditions Studied
Interventions
- DEVICE Trident II Tritanium Acetabular Shell
Study Locations (9)
New York
- Hospital for Special Surgery - New York
- Northwell Health, Lenox Hill Hospital - New York
Arizona
- Tucson Orthopaedic Institute - Tucson
Florida
- Southeast Orthopedic Specialists - Jacksonville
Illinois
- American Hip Institute - Des Plaines
Louisiana
- Center for Orthopaedics and Spine, LLC - Lake Charles
Michigan
- St. Joseph Mercy Hospital Health System - Ypsilanti
New Jersey
- Rothman Institute - Egg Harbor
North Carolina
- UNC Orthopaedics - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2017-01-20 |
| Est. Completion | 2031-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02999009
The ClinicalTrials.gov registry entry for NCT02999009 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthroplasty, Replacement, Hip appearing as the primary indexed condition, and to 1 intervention - of which Trident II Tritanium Acetabular Shell is the first listed.
NCT02999009 reports 9 study locations spanning 8 distinct geographic areas - top geographies include New York, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT02999009 about?
NCT02999009 is a clinical study titled "Trident II Tritanium Acetabular Shell Outcomes Study". The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much thi...
What is the current status of trial NCT02999009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 383 participants. The study started on 2017-01-20. Estimated completion is 2031-03.
What conditions does trial NCT02999009 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Hip.
What interventions are being tested in trial NCT02999009?
The interventions under investigation include: Trident II Tritanium Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT02999009?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02999009 being conducted?
This trial has 9 study locations across Arizona, Florida, Illinois, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.